Effects of selective inhibitors of neuronal nitric oxide synthase on carrageenan-induced mechanical and thermal hyperalgesia

Neuropharmacology

Volumn 37, Issue 1, 1998, Pages 37-43

  Handy, Rachel L c ^a   Moore, Phillip K ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

1 (2 trifluoromethylphenyl) imidazole; 7 nitroindazole; Carrageenan; Hyperalgesia; Nitric oxide synthase

Indexed keywords

7 NITROINDAZOLE 1 (2 TRIFLUOROMETHYLPHENYL)IMIDAZOLE; CARRAGEENAN; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOSE RESPONSE; ENZYME INHIBITION; HEMODYNAMICS; HYPERALGESIA; MALE; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; THERMAL INJURY;

ANIMALS; CARRAGEENAN; ENZYME INHIBITORS; IMIDAZOLES; INDAZOLES; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; PAIN THRESHOLD; RATS; RATS, WISTAR;

EID: 0031807427     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00201-3     Document Type: Article

References (25)

1. Bessou R.E., Perl E.R. Response of cutaneous sensory units with unmyelinated fibres to noxious stimuli. J. Neurophysiol. 32:1976;1025-1043.
2. Coderre T.J., Yashpal K Intracellular messengers contributing to persistent nociception and hyperalgesia induced by L-glutamate and substance P in the rat formalin pain model. Eur. J. Neurosci. 6:1994;1328-1334.
3. Handy R.L.C., Moore P.K. The nitric oxide synthase inhibitor, 7-nitroindazole, inhibits carrageenan-induced hindpaw oedema in the rat. Br. J. Pharmacol. 119:1996;157P.
4. Handy R.L.C., Moore P.K. 7-nitroindazole inhibits carrageenan-induced mechanical hyperalgesia in the rat. Pharmacologist. 39:1997;488P.
5. Handy R.L.C., Wallace P., Gaffen Z.A, Whitehead K.J., Moore P.K. 1-(2-Trifluoromethylphenyl) imidazole (TRIM): a potent inhibitor of neuronal nitric oxide synthase in vitro is antinociceptive in the mouse. Br. J. Pharmacol. 116:1995;2349-2350.
6. Handy R.L.C., Harb H.L., Wallace P., Gaffen Z., Whitehead K.J., Moore P.K. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects. Br. J. Pharmacol. 119:1996;423-431.
7. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
8. Ialenti A., Ianaro A., Moncada S., DiRosa M. Modulation of acute inflammation by endogenous nitric oxide. Eur. J. Pharmacol. 211:1992;177-182.
9. Laird J.M.A., Mason G.S., Webb J., Hill R.G., Hargreaves R.J. Effects of a partial agonist and a full antagonist acting at the glycine site of the NMDA receptor on inflammation-induced mechanical hyperalgesia in rats. Br. J. Pharmacol. 117:1996;1487-1492.
10. Malmberg A.B., Yaksh T.L. Spinal nitric oxide synthesis inhibition blocks NMDA induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain. 54:1993;291-300.
11. Meller S.T., Gebhart G.F. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain. 52:1993;127-136.
12. Meller S.T., Cummings C.P., Traub R.J., Gebhart G.F. The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat. Neuroscience. 60:1994;367-374.
13. Millan M.J., Seguin L. HA-966, a partial agonist at the glycine site coupled to NMDA receptors, blocks formalin-induced pain in mice. Eur. J. Pharmacol. 238:1993;445-557.
14. G-nitro arginine (L-NOARG)-a novel, L-arginine reversible inhibitor of endothelium-dependent vasodilatation. Br. J. Pharmacol. 99:1990;408-412.
15. G nitroarginine methyl ester exhibits antinociceptive activity in the mouse. Br. J. Pharmacol. 102:1991;198-202.
16. Moore P.K., Wallace P., Gaffen Z.A., Hart S.L., Babbedge R.C. 7-nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br. J. Pharmacol. 108:1993a;296-297.
17. Moore P.K., Wallace P., Gaffen Z., Hart S.L., Babbedge R.C. Characterisation of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects. Br. J. Pharmacol. 110:1993b;219-224.
18. G-nitro arginine methyl ester (L-NAME) and flurbiprofen in the mouse. Br. J. Pharmacol. 106:1992;493-497.
19. Randich A., Maixner W. Interactions between cardiovascular and pain regulatory systems. Neurosci. Behav. Rev. 8:1984;343-367.
20. Rees D.D., Palmer R.M.J., Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. USA. 86:1990;3375-3378.
21. Ren K., Williams G.M., Hylden L.K., Ruda M.A., Dubner R. The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioural hyperalgesia in rats. Eur. J. Pharmacol. 219:1992;235-243.
22. Salvemini D., Wang Z-Q., Wyatt P.A., Bourdon D.M., Marino M.H., Manning P.T., Currie M.G. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br. J. Pharmacol. 118:1996;829-838.
23. Semos M.L., Headley P.M. The role of nitric oxide in spinal nociceptive reflexes in rats with neurogenic and non-neurogenic peripheral inflammation. Neuropharmacology. 33:1994;1487-1497.
24. Willis W.D. Hyperalgesia and Allodynia. 1992;Raven Press, New York.
25. Woolf C.J. Evidence for a central component of post-injury pain hypersensitivity. Nature. 308:1993;686-688.